How do women and health care professionals view hormonal long-acting reversible contraception?
Standard
How do women and health care professionals view hormonal long-acting reversible contraception? Results from an international survey. / Faustmann, Thomas; Crocker, John; Moeller, Carsten; Engler, Yvonne; Caetano, Cecilia; Buhling, Kai J.
in: EUR J CONTRACEP REPR, Jahrgang 24, Nr. 6, 12.2019, S. 422-429.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - How do women and health care professionals view hormonal long-acting reversible contraception?
T2 - Results from an international survey
AU - Faustmann, Thomas
AU - Crocker, John
AU - Moeller, Carsten
AU - Engler, Yvonne
AU - Caetano, Cecilia
AU - Buhling, Kai J
PY - 2019/12
Y1 - 2019/12
N2 - Purpose: Evidence from real-world settings is important to provide an accurate picture of health care delivery. We investigated use of long-acting reversible contraception (LARC) in women aged 15-49 years.Materials and methods: Two surveys, one of women and one of health care professionals (HCPs), were conducted in parallel across seven countries. Participating women completed an online survey to assess contraceptive awareness, current method of contraception, age, and experience with current contraceptive method. HCPs participated in an online survey to provide practice-level information and three anonymous charts of hormonal LARC users.Results: Of 6903 women who completed the survey, 3225 provided information about their current primary contraception method. Overall, 16% used LARC methods, while 52% used oral contraceptives (OCs). Of hormonal intrauterine system users, 72% described their experience as 'very favourable', compared with only 53% of women using OCs. Anonymous patient records (n = 1605) were provided by 550 HCPs who completed the online survey. Most women (64%) had used short-acting reversible contraception before switching to LARC. Physicians perceived 56-84% of LARC users to be highly satisfied with their current form of contraception.Conclusions: Although usage of LARC was low, most women using LARC were highly satisfied with their method of contraception.
AB - Purpose: Evidence from real-world settings is important to provide an accurate picture of health care delivery. We investigated use of long-acting reversible contraception (LARC) in women aged 15-49 years.Materials and methods: Two surveys, one of women and one of health care professionals (HCPs), were conducted in parallel across seven countries. Participating women completed an online survey to assess contraceptive awareness, current method of contraception, age, and experience with current contraceptive method. HCPs participated in an online survey to provide practice-level information and three anonymous charts of hormonal LARC users.Results: Of 6903 women who completed the survey, 3225 provided information about their current primary contraception method. Overall, 16% used LARC methods, while 52% used oral contraceptives (OCs). Of hormonal intrauterine system users, 72% described their experience as 'very favourable', compared with only 53% of women using OCs. Anonymous patient records (n = 1605) were provided by 550 HCPs who completed the online survey. Most women (64%) had used short-acting reversible contraception before switching to LARC. Physicians perceived 56-84% of LARC users to be highly satisfied with their current form of contraception.Conclusions: Although usage of LARC was low, most women using LARC were highly satisfied with their method of contraception.
KW - Adolescent
KW - Adult
KW - Age Factors
KW - Attitude of Health Personnel
KW - Awareness
KW - Contraceptive Devices, Female
KW - Contraceptives, Oral/administration & dosage
KW - Europe
KW - Female
KW - Humans
KW - Long-Acting Reversible Contraception/psychology
KW - Middle Aged
KW - North America
KW - Patient Preference
KW - Patient Satisfaction
KW - Young Adult
U2 - 10.1080/13625187.2019.1666362
DO - 10.1080/13625187.2019.1666362
M3 - SCORING: Journal article
C2 - 31559869
VL - 24
SP - 422
EP - 429
JO - EUR J CONTRACEP REPR
JF - EUR J CONTRACEP REPR
SN - 1362-5187
IS - 6
ER -